Breast Cancer
Conference Coverage
Extent of breast surgery is tied to quality of life among young breast cancer survivors
SAN ANTONIO – Younger breast cancer patients who undergo unilateral or bilateral mastectomy report lower breast satisfaction and poorer...
Conference Coverage
pCR may obviate need for adjuvant chemotherapy
SAN ANTONIO – A meta-analysis finds no added event-free survival benefit from adjuvant chemotherapy among the 21.1% of patients who achieved a pCR...
Conference Coverage
Extended anastrozole improves DFS, distant DFS
SAN ANTONIO – Extending treatment to 10 years significantly improved DFS and distant DFS in postmenopausal women...
Conference Coverage
Tamoxifen at 5 mg halves recurrence of breast intraepithelial neoplasia
SAN ANTONIO – For patients with ADH, DCIS, or LCIS, one-fourth of the standard dose reduced risk for both invasive disease/DCIS and contralateral...
Conference Coverage
TNBC survival appears better when adjuvant chemotherapy is delivered within 30 days
SAN ANTONIO – The longer the delay in initiating adjuvant chemotherapy, the worse the survival in patients with...
Conference Coverage
CTC matches MD judgment for mBC therapeutic choice
SAN ANTONIO – For patients with ER-positive, HER2-negative metastatic breast cancer, the use of CTC counts can help clinicians decide between...
Conference Coverage
RT of lymph nodes as good as dissection for the long-term
SAN ANTONIO – Both axillary RT and axillary lymph node dissection provide excellent, comparable locoregional control in patients with early-stage...
Conference Coverage
Nothing to gain from chemo after pCR achieved
SAN ANTONIO - The only thing women with localized breast cancer who achieve a pCR after neoadjuvant chemo may gain from further chemo from...
Conference Coverage
Small absolute difference between partial and whole breast irradiation
SAN ANTONIO – A phase 3 trial was unable to rule out the possibility that, after lumpectomy, partial breast irradiation is inferior to whole...
News
Low-dose tamoxifen halves recurrence of breast intraepithelial neoplasia
SAN ANTONIO – Women with breast intraepithelial neoplasms who took tamoxifen for 3 years at a dose of 5 mg per day had a 50% reduction in risk of...